Press Releases
- Dec 6, 2016- CEO, Jim McGorry, to participate in presentation and panel discussion on Wednesday, December 7th at 2:00 PM ET -
Biostage, Inc. (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the...
- Dec 1, 2016
Biostage, Inc. (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the...
- Nov 22, 2016- No immediate effect on the Company's Nasdaq listing or the trading of its common stock -
Biostage, Inc. (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the...
- Nov 10, 2016- Growing body of proof-of-concept preclinical data from ongoing studies continue to be replicated to show clear pattern of regeneration
Biostage, Inc. (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the...
- Nov 3, 2016- Conference Call with Live Audio Webcast on Thursday, November 10 at 9:00 a.m. ET -
Biostage, Inc. (Nasdaq: BSTG), ("Biostage" or the "Company"), a biotechnology company developing bioengineered organ implants to treat cancers and other life-threatening conditions of the...
